Advertisement
Advertisement
Nurtec ODT

Nurtec ODT

rimegepant

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma

Marketer:

Pfizer
Concise Prescribing Info
Contents
Rimegepant sulfate
Indications/Uses
Acute treatment of migraine w/ or w/o aura in adults. Preventive treatment of episodic migraine in adults.
Dosage/Direction for Use
Acute treatment of migraine 75 mg as needed, once daily. Migraine prophylaxis 75 mg every other day. Max dose: 75 mg/day.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Discontinue use & initiate appropriate therapy if hypersensitivity reaction occurs; if medication overuse headache occurs or suspected. Avoid another dose w/in 48 hr when concomitantly administered w/ moderate CYP3A4 inhibitors (fluconazole). Not recommended for concomitant use w/ strong CYP3A4 inhibitors & strong or moderate CYP3A4 inducers. Not recommended in patients w/ severe hepatic impairment; ESRD (CrCl <15 mL/min). Avoid during pregnancy. Lactation. Paed <18 yr. Elderly ≥65 yr.
Drug Interactions
Increased plasma conc w/ strong CYP3A4 inhibitors (eg, clarithromycin, itraconazole, ritonavir); P-gp & BCRP efflux transporters (eg, cyclosporine, verapamil, quinidine). May increase exposure w/ moderate CYP3A4 inhibitors (eg, diltiazem, erythromycin, fluconazole). Decreased plasma conc w/ strong (eg, phenobarb, rifampicin, St. John's wort) or moderate (eg, bosentan, efavirenz, modafinil) CYP3A4 inducers.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD06 - rimegepant ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Nurtec ODT OD tab 75 mg
Packing/Price
1 × 8's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement